As of Mar 28
| +0.0059 / +1.47%|
The 3 analysts offering 12-month price forecasts for AIM ImmunoTech Inc have a median target of 6.50, with a high estimate of 6.75 and a low estimate of 3.00. The median estimate represents a +1,500.99% increase from the last price of 0.41.
The current consensus among 3 polled investment analysts is to Buy stock in AIM ImmunoTech Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.